Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis

Background: Hepatic stellate cells (HSCs) are a major fibrogenic cell type that contributes to collagen accumulation during chronic liver disease. With increasing interest in developing antifibrotic therapies, there is a need for cell lines that preserve the in vivo phenotype of human HSCs to elucidate pathways of human hepatic fibrosis. We established and characterised two human HSC cell lines termed LX-1 and LX-2, and compared their features with those of primary human stellate cells. Methods and results: LX-1 and LX-2 were generated by either SV40 T antigen immortalisation (LX-1) or spontaneous immortalisation in low serum conditions (LX-2). Both lines express α smooth muscle actin, vimentin, and glial fibrillary acid protein, as visualised by immunocytochemistry. Similar to primary HSCs, both lines express key receptors regulating hepatic fibrosis, including platelet derived growth factor receptor β (βPDGF-R), obese receptor long form (Ob-RL), and discoidin domain receptor 2 (DDR2), and also proteins involved in matrix remodelling; matrix metalloproteinase (MMP)-2, tissue inhibitor of matrix metalloproteinase (TIMP)-2, and MT1-MMP, as determined by western analyses. LX-2 have reduced expression of TIMP-1. LX-2, but not LX-1, proliferate in response to PDGF. Both lines express mRNAs for α1(I) procollagen and HSP47. Transforming growth factor β1 stimulation increased their α1(I) procollagen mRNA expression, as determined by quantitative reverse transcription-polymerase chain reaction. LX-2, but not LX-1, cells are highly transfectable. Both lines had a retinoid phenotype typical of stellate cells. Microarray analyses showed strong similarity in gene expression between primary HSCs and either LX-1 (98.4%) or LX-2 (98.7%), with expression of multiple neuronal genes. Conclusions: LX-1 and LX-2 human HSC lines provide valuable new tools in the study of liver disease. Both lines retain key features of HSCs. Two unique advantages of LX-2 are their viability in serum free media and high transfectability.

[1]  R. Kalluri,et al.  Liver fibrosis: insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors. , 2003, Gastroenterology.

[2]  Hsin C. Lin,et al.  Discoidin Domain Receptor 2 Interacts with Src and Shc following Its Activation by Type I Collagen* , 2002, The Journal of Biological Chemistry.

[3]  L. O’Driscoll,et al.  Survivin: role in normal cells and in pathological conditions. , 2003, Current cancer drug targets.

[4]  S. Friedman.  Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury* , 2000, The Journal of Biological Chemistry.

[5]  Hsin C. Lin,et al.  DDR 2 receptor promotes MMP-2 – mediated proliferation and invasion by hepatic stellate cells , 2001 .

[6]  R. Shippy,et al.  An assessment of Motorola CodeLink microarray performance for gene expression profiling applications. , 2002, Nucleic acids research.

[7]  K. Mak,et al.  Leptin Stimulates Tissue Inhibitor of Metalloproteinase-1 in Human Hepatic Stellate Cells , 2004, Journal of Biological Chemistry.

[8]  T. Masuda,et al.  Establishment of a new human cell line, LI90, exhibiting characteristics of hepatic Ito (fat-storing) cells. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[9]  L. Hendershot,et al.  Protein-specific chaperones: The role of hsp47 begins to gel , 2000, Current Biology.

[10]  D. Dorris,et al.  Oligodeoxyribonucleotide probe accessibility on a three-dimensional DNA microarray surface and the effect of hybridization time on the accuracy of expression ratios , 2003, BMC biotechnology.

[11]  G. Raju.  Hemoclips–clips to clasp the bleeder , 2002 .

[12]  J. Iredale.  Hepatic Stellate Cell Behavior during Resolution of Liver Injury , 2001, Seminars in liver disease.

[13]  W. Sessa,et al.  Inhibitor of apoptosis protein survivin regulates vascular injury , 2002, Nature Medicine.

[14]  D. Brenner,et al.  Cytokines induce NF-kappaB in activated but not in quiescent rat hepatic stellate cells. , 1998, The American journal of physiology.

[15]  Jonathan Pevsner,et al.  SNOMAD (Standardization and NOrmalization of MicroArray Data): web-accessible gene expression data analysis , 2002, Bioinform..

[16]  Y. Takei,et al.  Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat. , 2002, Gastroenterology.

[17]  J. Gauthier,et al.  Characterization of a new human liver myofibroblast cell line: transcriptional regulation of plasminogen activator inhibitor type I by transforming growth factor beta 1. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[18]  S. Friedman,et al.  Lipocytes from normal rat liver release a neutral metalloproteinase that degrades basement membrane (type IV) collagen. , 1989, The Journal of clinical investigation.

[19]  J. Prieto,et al.  Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy. , 1991, The New England journal of medicine.

[20]  C. Abbott,et al.  Fibroblast activation protein: A cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis , 1999, Hepatology.

[21]  S. Friedman,et al.  Leptin in hepatic fibrosis: Evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice , 2002, Hepatology.

[22]  W. Blaner,et al.  Biochemical characteristics of isolated rat liver stellate cells , 1987, Hepatology.

[23]  D. Schuppan,et al.  Matrix as a modulator of hepatic fibrogenesis. , 2001, Seminars in liver disease.

[24]  H. Shibata,et al.  Immediate onset of DNA synthesis in remnant rat liver after 90% hepatectomy by an administration of follistatin. , 1998, Journal of hepatology.

[25]  I. Verma,et al.  Adenovirus‐mediated overexpression of follistatin enlarges intact liver of adult rats , 2003, Hepatology.

[26]  M. Arthur,et al.  High efficiency gene transfer into cultured primary rat and human hepatic stellate cells using baculovirus vectors. , 2002, Liver.

[27]  D. Brenner,et al.  Immortal Activated Human Hepatic Stellate Cells Generated by Ectopic Telomerase Expression , 2002, Laboratory Investigation.

[28]  A. Gressner,et al.  Tumor‐dependent activation of rodent hepatic stellate cells during experimental melanoma metastasis , 1997, Hepatology.

[29]  S. Friedman,et al.  An immortalized rat liver stellate cell line (HSC-T6): a new cell model for the study of retinoid metabolism in vitro. , 2000, Journal of lipid research.

[30]  T. Roskams,et al.  Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers. , 2001, Journal of hepatology.

[31]  G. Gores,et al.  Activated stellate cells express the TRAIL receptor‐2/death receptor‐5 and undergo TRAIL‐mediated apoptosis , 2003, Hepatology.

[32]  John P. Iredale,et al.  Inhibition of Apoptosis of Activated Hepatic Stellate Cells by Tissue Inhibitor of Metalloproteinase-1 Is Mediated via Effects on Matrix Metalloproteinase Inhibition , 2002, The Journal of Biological Chemistry.

[33]  V. Desmet,et al.  Human and rat hepatic stellate cells express neurotrophins and neurotrophin receptors. , 2001, Hepatology.

[34]  S. Friedman,et al.  DDR2 receptor promotes MMP-2-mediated proliferation and invasion by hepatic stellate cells. , 2001, The Journal of clinical investigation.

[35]  K. Wake,et al.  Zonal and regional differences identified from precision mapping of vitamin a–storing lipid droplets of the hepatic stellate cells in pig liver: A novel concept of addressing the intralobular area of heterogeneity , 1998, Hepatology.

[36]  N. Levitt,et al.  Autonomic neuropathy in extra-hepatic portal vein thrombosis: evidence for impaired autonomic reflex arc. , 1997, Journal of hepatology.

[37]  S. Friedman,et al.  Isolated hepatic lipocytes and kupffer cells from normal human liver: Morphological and functional characteristics in primary culture , 1992, Hepatology.

[38]  S. Friedman,et al.  Maintenance of differentiated phenotype of cultured rat hepatic lipocytes by basement membrane matrix. , 1989, The Journal of biological chemistry.

[39]  Tetsuji Sato,et al.  Intralobular heterogeneity of perisinusoidal stellate cells in porcine liver , 1993, Cell and Tissue Research.

[40]  K. Sugano,et al.  Activin A is an autocrine activator of rat pancreatic stellate cells: potential therapeutic role of follistatin for pancreatic fibrosis , 2003, Gut.

[41]  S. Friedman,et al.  Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture. , 1994, The Journal of clinical investigation.

[42]  E. Wisse,et al.  Tissue distribution, quantitation and proliferation kinetics of fat‐storing cells in carbon tetrachloride–injured rat liver , 1991, Hepatology.

[43]  S. Friedman,et al.  Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. Direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet-derived growth factor receptors. , 1989, The Journal of clinical investigation.

[44]  D. Rockey,et al.  Hepatic Blood Flow Regulation by Stellate Cells in Normal and Injured Liver , 2001, Seminars in liver disease.

[45]  N. Enomoto,et al.  Leptin is required for fibrogenic responses induced by thioacetamide in the murine liver , 2002, Hepatology.

[46]  S. Thorgeirsson,et al.  Cellular distribution of transforming growth factor-beta 1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis. , 1990, The Journal of clinical investigation.

[47]  C. H. Ong,et al.  Progranulin is a mediator of the wound response , 2003, Nature Medicine.

[48]  J. Decaprio,et al.  Cellular transformation by SV40 large T antigen: interaction with host proteins. , 2001, Seminars in cancer biology.